New environmentlal technology to produce standarized raw materials of medicinal plants and high-yield species of plants
||Active until 15.02.2019|
|Profile code: 4241||Technology offer|
A company from Novosibirsk region of Russia has developed an environmentally friendly technology to produce standardized raw materials of medicinal plants and to develop new high-yield species of plants, including rare, for the creation of industrial plantations. New, highly productive forms of plants suitable for industrial plantations are obtained with this technology. The company is interested in finding a partner for joint venture for industrial cultivation of medicinal herbs.
The Russian company from Novosibirsk specializes in the cultivation and harvesting of medicinal plants, manufacturing of final products (teas, balms, food ingredients) is interested in finding a partner for joint venture for industrial cultivation of medicinal herbs. The company uses technology of microcloning of saplings, suitable for obtaining plants in industrial volumes for manufacturing of raw materials, including such rare plants as Rhodiola rosea (golden root). The company conducted 5-years field testing of technology, and now is preparing patent applications for a highly productive plant variety and a method of reproduction. Company has technology and plantations, and is looking for a partner, interested in industrial manufacture of raw materials, for joint venture agreement. The result of cooperation will be joint manufacture of medicinal plants that can be later sold and used as a raw material. Type of cooperation: joint venture agreement. Partner should have an experience of production or use of medicinal plants and should be interested in buying big amount of plants for sale or use in manufacture.
The technology is aimed at manufacturing industrial quantities of medicinal plants, including rare, such as Rhodiola rosea (golden root). Rhodiola rosea is an endangered species, which maturity period is 5 years. This plant has a number of useful properties, similar to the properties of ginseng, and is widely used in the manufacture of drugs. The plant is highly demanded on the market. Cultivation of Rhodiola rosea holds great promise as a drug for the industrial production, as well as for preserving this rare plant in nature. The technology is adapted and for other plant species, including rare and sought-after in the pharmaceutical and food market, such as thyme, echinacea, St. John's Wort, ginseng, and others. The proposed technology involves the use of biotechnology clonal micropropagation in vitro, which is used 1) to obtain the standard saplings in large numbers, 2) to obtain high quality planting material, absolutely identical to the parent plant. Currently on the market plant propagation technology of budding is used.
Main offer's advantages
The downside of traditional technology is labour-intensity (requires up to 20 people and 6 months of work). The proposed technology requires 1 person and 1 month of work to create 40.000 seedlings. Laboratory studies were conducted on clonal micropropagation of Rhodiola rosea. Five-year trials on the organization of experimental plantations of Rhodiola rosea on the area of 1 hectare in the mountain regions have been completed successfully. The company also raised the federal grant funds for R & D. The company has nearly 10 years of experience in the cultivation and harvesting of over 60 types of herbs that are available for the production of pharmaceutical and food products.
In vitro Testing, Trials ; Horticulture ; Food Additives / Ingredients
Current stage of development
Available for demonstration – field tested
Patent application obtained
Property right comments
The company is preparing applications for patents for a method of reproduction of Rhodiola rosea in vitro and a highly productive sort of Rhodiola rosea.
Type of collaboration sought
Joint Venture Agreement
Type of partner: medium enterprise. Field of activity: manufacture of medicinal plants or pharmaceutical products made of these plants. Partner's role: joint venture for industrial cultivation of medicinal plants (raw material).
If you are interested in this project, please leave information about yourself here: